Keyphrases
Melatonin
100%
Betaine
100%
Diabetic Rats
100%
Flaxseed
100%
Gum Acacia
100%
Chronic Kidney Disease
100%
Vascular Complications
22%
Diabetes Mellitus
22%
Anti-inflammatory Index
11%
Inflammation Oxidative Stress
11%
Blood Feeding
11%
Patients with Diabetes Mellitus
11%
Anti-inflammatory Properties
11%
Western Blotting
11%
Cystatin C (Cys C)
11%
Physiological Parameters
11%
Creatinine Clearance
11%
Fecal Output
11%
Treatment Effect
11%
Urine Output
11%
Conventional Index
11%
Body Weight Changes
11%
Chronic Metabolic Diseases
11%
Nrf2 Pathway
11%
Adjunctive Therapy
11%
Nitrosative
11%
Biochemical Measurements
11%
Histopathological Parameters
11%
Kidney Weight
11%
Molecular Parameters
11%
Global Prevalence
11%
Nicotinamide
11%
Water Intake
11%
Streptozotocin
11%
Antioxidant System
11%
Blood Pressure
11%
Feed Intake
11%
Antioxidant
11%
Apoptosis
11%
Inflammation
11%
Biochemical Parameters
11%
Physiological Measurement
11%
Creatinine
11%
Public Health Risk
11%
Urea
11%
Immunohistochemistry
11%
Diabetes
11%
Pathophysiology
11%
High Prevalence
11%
Medicine and Dentistry
Gum Arabic
100%
Experimental Chronic Renal Failure
100%
Chronic Kidney Disease
100%
Trimethylglycine
100%
Diabetes Mellitus
100%
Melatonin
100%
Adenine
25%
Antioxidant
25%
Anti-Inflammatory Drug
25%
Prevalence
25%
Transcription Factor Nrf2
12%
Water-Electrolyte Imbalance
12%
Biological Marker
12%
Blood Pressure
12%
Programmed Cell Death
12%
Immunohistochemistry
12%
Diabetes
12%
Pathophysiology
12%
Oxidative Stress
12%
Creatinine Clearance
12%
Water Intake
12%
Western Blot
12%
Cystatin C
12%
Microvascular Complication
12%
Kidney Homogenate
12%
Neutrophil Gelatinase Associated Lipocalin
12%
Nicotinamide
12%
Creatinine
12%
Adjuvant Therapy
12%
Streptozocin
12%
Diseases
12%
Patient with Diabetes
12%
Public Health
12%
Signal Transduction
12%
INIS
gum acacia
100%
betaine
100%
melatonin
100%
diseases
100%
rats
100%
kidneys
100%
inflammation
45%
diabetes mellitus
27%
urine
18%
creatinine
18%
animals
18%
adenines
18%
oxidation
18%
clearance
9%
nicotinamide
9%
injection
9%
urea
9%
capacity
9%
therapy
9%
antioxidants
9%
mortality
9%
plasma
9%
blood pressure
9%
proteins
9%
streptozotocin
9%
water
9%
apoptosis
9%
homogenates
9%
humans
9%
intake
9%
biological markers
9%
patients
9%
output
9%
morbidity
9%
public health
9%
metabolic diseases
9%
weight
9%